Wasley, A, Fiore, A, Bell, BP. Hepatitis A in the era of vaccination. Epidemiologic Reviews
2006; 28: 101–111.
Craig, AS, Schaffner, W. Prevention of hepatitis A with the hepatitis A vaccine. New England Journal of Medicine
2004; 350: 476–481.
World Health Organization. WHO position paper on hepatitis A vaccines – June 2012. Weekly Epidemiological Record
2012; 87: 261–276.
Hanafiah, KM, Jacobsen, KH, Wiersma, ST. Challenges to mapping the health risk of hepatitis A virus infection. International Journal of Health Geographics
2011; 10: 57.
Jacobsen, KH, Wiersma, ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine
2010; 28: 6653–6657.
United Nations Children's Fund (UNICEF), World Health Organization. Progress on drinking water and sanitation: 2013 update. New York: WHO and UNICEF, 2013.
Farajzadegan, Z, et al.
Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. Journal of Research in Medical Sciences
2014; 19: S56–S63
Merat, S, et al.
Seroprevalence and risk factors of hepatitis a virus infection in Iran: a population based study. Archives of Iranian Medicine
2010; 13: 99–104.
Mohebbi, SR, et al.
Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Transactions of the Royal Society of Tropical Medicine & Hygiene
2012; 106: 528–531.
Noroozi, M, et al.
Seroprevalence of hepatitis A and hepatitis E in Qom Province, 2011. Iranian Journal of Infectious Diseases & Tropical Medicine
2012; 17: 19–23.
Khashayar, P, et al.
Metabolic syndrome and cardiovascular risk factors in a national sample of adolescent population in the middle east and north Africa: the CASPIAN III study. International Journal of Endocrinology
2013; 2013: 702095.
Farzadfar, F, et al.
National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Population Health Metrics
2011; 9: 55.
Iranian National Organization for Civil Registration. Population statistics of the country in 2009. Tehran: Deputy of Information Technology and Demographic Statistics, 2010.
United Nations Children's Fund (UNICEF), World Health Organization. Immunization summary (updated 2013). New York: UNICEF and WHO, 2013.
Daniels, D, Grytdal, S, Wasley, A. Surveillance for acute viral hepatitis – United States, 2007. Morbidity and Mortality Weekly Report (Surveillance Summary)
2009; 58: 1–27.
Bialek, SR, et al.
Hepatitis A incidence and hepatitis A vaccination among American Indians and Alaska Natives, 1990–2001. American Journal of Public Health
2004; 94: 996–1001
Cui, F, et al.
Hepatitis A surveillance and vaccine use in China from 1990 through 2007. Journal of Epidemiology
2009; 19: 189–195.
Blanco Fernandez, MD, et al.
Analysis of the circulation of hepatitis A virus in Argentina since vaccine introduction. Clinical Microbiology and Infection
2012; 18: E548–551.
Anonychuk, AM, et al.
Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. Pharmacoeconomics
2008; 26: 17–32.
Salama, I, et al.
Seroprevalence of hepatitis A among children of different socioeconomic status in Cairo. Eastern Mediterranean Health Journal
2007; 13: 1256–1264.
Turky, AM, et al.
Analysis of acute viral hepatitis (A and E) in Iraq. Global Journal of Health Science
2011; 3: 70–76.
Almuneef, M, et al.
Epidemiologic shift in the prevalence of hepatitis A virus in Saudi Arabia: a case for routine hepatitis A vaccination. Vaccine
2006; 24: 5599–5603.